site stats

Linagliptin and bullous pemphigoid

NettetExplore 190 research articles published on the topic of “Bullous pemphigoid” in 2024. Over the lifetime, 4290 publication(s) have been published within this topic receiving … Nettet21. aug. 2024 · Physical examination showed blisters and bullae on the flexural surface of both of his arms, lower abdomen, back and upper thighs. The lesions were filled with …

National Center for Biotechnology Information

Nettet8. jun. 2024 · Following the diagnosis of chronic kidney disease, her metformin therapy was stopped and vildagliptin was replaced by linagliptin 5mg/24h. One month later, … NettetNational Center for Biotechnology Information sports acupuncture boulder https://xquisitemas.com

Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a …

Nettet1. mar. 2024 · Sir, Drug-induced bullous pemphigoid (BP) is associated with tumor necrosis factor-α (TNF-α) antagonists and dipeptidyl peptidase-4 (DPP-4) inhibitors.[1,2,3,4] Herein, we report a psoriatic patient; in whom adalimumab, a TNF-α antagonist and linagliptin, a DPP-4 inhibitor are implicated in BP development.A 62 … Nettet4. mai 2024 · It was recently reported that some cases of bullous pemphigoid (BP) were induced by dipeptidyl peptidase (DPP)-4 inhibitors used for the treatment of type … Nettet10. sep. 2024 · This is the first report of linagliptin-associated alopecia areata and bullous pemphigoid (BP), which may help demonstrate a link between DPP-4 … shelly led

Linagliptin/vildagliptin SpringerLink

Category:Association Between Bullous Pemphigoid and Dipeptidyl …

Tags:Linagliptin and bullous pemphigoid

Linagliptin and bullous pemphigoid

Superimposed Effects of Adalimumab and Linagliptin on the …

Nettet7. jun. 2024 · Linagliptin, sitagliptin, and combinations of metformin with vildagliptin and linagliptin were also associated with increased risk of BP. Sulfonylureas, SGLT2 inhibitors, or GLP-1 analogs were not associated with increased BP risk. Nettet4. mai 2024 · This is a case of bullous pemphigoid (BP) induced by linagliptin, which is a dipeptidyl peptidase‐4 inhibitors. In our case, the skin lesion was relieved by cancellation of the DPP‐4 inhibitor, but the esophagus lesion did not cure without steroid treatment.

Linagliptin and bullous pemphigoid

Did you know?

NettetBackground. Pemphigoid disorders are an uncommon, chronic, autoimmune, subepithelial, blistering disease that occurs more frequently among older adults and are characterised by the presence of … Nettet10. jun. 2024 · There are uncertainties regarding the association between dipeptidyl peptidase 4 (DPP-4) inhibitors and bullous pemphigoid (BP), a potentially severe. …

NettetWe describe two patients with pruritic, mainly urticarial or eczematous lesions associated with peripheral blood eosinophilia. No vesicles or blisters developed in either patient throughout the course of the disease (29 and 38 months, respectively). To characterize the clinicopathologic features of these patients we performed histopathologic studies, direct … NettetBullous Pemphigoid is an autoimmune blistering disorder in which autoantibodies target components of hemidesmosomes within the skin's basement membrane, …

Nettet10. jun. 2024 · A potential signal was also observed in the Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) trial, where a numerical imbalance of BP events was reported (linagliptin vs. placebo: seven vs. zero events) ( 29 ). NettetBullous pemphigoid (BP) is the most common subepidermal bullous disease and involves an immune response directed against two hemidesmosome components in basal keratinocytes: BP antigen 180 (BP180) and BP antigen 230.

NettetWe describe a 76-year-old white woman with a 6-month history of intensive pruritus and excoriated papules resembling subacute prurigo. Histopathology showed signs of chronic dermatitis, whereas findings by direct and indirect immunofluorescence microscopy were compatible with bullous pemphigoid (BP). The patient's serum contained IgG …

NettetAlice Mouna Fayad is an academic researcher from Saint Joseph's University. The author has contributed to research in topic(s): Pemphigoid & Bullous pemphigoid. The author has an hindex of 1, co-authored 1 publication(s) receiving 34 citation(s). sports activity in goaNettetLinagliptin-induced bullous pemphigoid. Linagliptin-induced bullous pemphigoid Int J Dermatol. 2024 Dec;56(12):1467-1469. doi: 10.1111/ijd.13705. Epub 2024 Aug 1. … shelly ledermanNettet13. feb. 2024 · Bullous pemphigoid.* Hypoglycemia ... Note: The combination of linagliptin, the active drug in Tradjenta, and metformin, is available as the brand-name … shelly ledford